American Shared Hospital Services (AMS)

American Shared Hospital Services (AMS) experienced a Q4 2025 earnings miss with an EPS of -$0.09 and revenue down 14.8% year-over-year. For the full year 2025, AMS reported a net loss of $1.6 million, with total revenue slightly decreasing from 2024. The medical equipment leasing segment's revenue declined by 33.9% in Q4 2025, and the gross margin significantly dropped to 12%. The company's cash position decreased to $3.7 million at the end of 2025. Certain financial covenants were not met due to lower profitability. AMS announced a seven-year PBRT lease extension with Orlando Health through 2033. The stock has been trading near its 52-week low, declining by 25.44% over the past year.

The provided search results do not contain explicit information regarding the demand seasonality for American Shared Hospital Services' products and services. Demand for medical treatments like radiation therapy can sometimes be influenced by factors such as patient deductibles resetting, holiday periods, and flu seasons, which might lead to some fluctuations in patient volumes.

American Shared Hospital Services (AMS) operates in the Healthcare sector, focusing on Finance/Rental/Leasing, Medical Instruments, and Services-Medical Laboratories. The company leases medical equipment and provides direct patient care services. AMS leases radiosurgery and radiation therapy machines, such as Gamma Knife and proton beam systems, to hospitals, accounting for 50.5% of its Q2 2025 revenue. The company runs treatment centers in the U.S. and Latin America, offering cancer and brain disorder therapies directly to patients, representing 49.5% of total revenue in Q2 2025. AMS is a leader in Gamma Knife unit ownership, providing non-invasive procedures. AMS provides PBRT through a joint venture in Orlando, Florida, and offers financing for hospitals to acquire Gamma Knife units. AMS offers advanced therapies such as IMRT, IGRT, SBRT, and SRS through LINAC and MR-guided Linacs. AMS offers financing for hospitals to acquire equipment and provides support services to healthcare providers.

American Shared Hospital Services has facilities in the United States and Latin America. In the U.S., AMS has expanded its direct patient services, including acquiring a stake in Rhode Island radiation therapy centers, and operates a Proton Beam Radiation Therapy facility in Orlando, Florida. In Latin America, AMS has a Gamma Knife facility in Peru, a Gamma Knife Center in Ecuador, and a new radiation therapy facility in Puebla, Mexico, with a joint venture in Guadalajara expected to start operations in late 2025.

Information specifically detailing "brand reputation" for American Shared Hospital Services in the past year is not explicitly available. Disappointing financial results, strategic shifts and expansions, and missed financial covenants could affect its reputation. The successful extension of the PBRT lease with Orlando Health could be viewed positively.

American Shared Hospital Services (AMS) has a mixed ownership structure. Institutional investors own approximately 9.46% to 12.17% of the company's stock, with Dimensional Fund Advisors Lp and Vanguard Group Inc being the largest shareholders. Insiders own approximately 24.65% of the company's stock, with Raymond Stachowiak owning the most shares. Public companies and individual investors hold a significant portion, ranging from 2.71% to 63.18% of the stock.